Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Sanchez

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
Journal of Immunology Research|August 28, 2020
Corrigendum to "Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring"Iole Macchia, Valentina La Sorsa, Irene Ruspantini, et al.
Nature Immunology|September 17, 2024
Author Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1BMartina Musella, Andrea Guarracino, Nicoletta Manduca, et al.
Nature Immunology|August 24, 2022
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1BMartina Musella, Andrea Guarracino, Nicoletta Manduca, et al.
Human Molecular Genetics|April 8, 2014
Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesisElisabetta Flex, Mamta Jaiswal, Francesca Pantaleoni, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
Journal of Immunology Research|August 28, 2020
Corrigendum to "Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring"Iole Macchia, Valentina La Sorsa, Irene Ruspantini, et al.
Nature Immunology|September 17, 2024
Author Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1BMartina Musella, Andrea Guarracino, Nicoletta Manduca, et al.
Nature Immunology|August 24, 2022
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1BMartina Musella, Andrea Guarracino, Nicoletta Manduca, et al.
Human Molecular Genetics|April 8, 2014
Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesisElisabetta Flex, Mamta Jaiswal, Francesca Pantaleoni, et al.
Pageof 12